authors

• Stephanie Cham, MD
• Matulonis, Ursula A
• Liu, Joyce F
• Xiong, Niya
• Tayob, Nabihah
• Krasner, Carolyn
• Wright, Alexi A
• Lee, Elizabeth K
• Sawyer, Hannah
• Mathews, Cara
• Konstantinopoulos, Panagiotis A

publication date

• June 24, 2025

published in

• Gynecologic oncology reports  Journal

Keywords

• Next generation sequencing
• Phase 2 trial
• TP53 mutation
• Uterine carcinosarcoma
• Wee1 inhibitor

Digital Object Identifier (DOI)

• https://doi.org/10.1016/j.gore.2025.101796

PubMed ID

• 40678577

start page

end page